AKIN GUMP STRAUSS HAUER & FELD for MCKESSON CORPORATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to COVID medical response; COVID-19 vaccine distribution; and health disparities; H.R. 7667, Food & Drug Amendments of 2022; S. 4348, the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN D'ARCY | — |
Pharmacy PHA
Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN D'ARCY | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.